Jul 20, 2026
The Grand Roundup: Payer Q2 earnings, HCA's ACA miss, OpenEvidence & Doximity's PR war, fee schedule backlash, Neko's $7B valuation, and more

The Grand Roundup: Payer Q2 earnings, HCA's ACA miss, OpenEvidence & Doximity's PR war, fee schedule backlash, Neko's $7B valuation, and more